Trial Profile
Effectiveness of referral system for the management of heart failure with tolvaptan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 11 Nov 2021 Status changed from active, no longer recruiting to completed.
- 10 Nov 2020 Status changed from recruiting to active, no longer recruiting.
- 10 Nov 2015 New trial record